Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 24831421)

Published in Pain on May 14, 2014

Authors

John T Farrar1, Andrea B Troxel2, Kevin Haynes2, Ian Gilron3, Robert D Kerns4, Nathaniel P Katz5, Bob A Rappaport6, Michael C Rowbotham7, Ann M Tierney2, Dennis C Turk8, Robert H Dworkin9

Author Affiliations

1: Department of Biostatistics and Epidemiology, Anesthesiology, and Neurology, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: jfarrar@upenn.edu.
2: University of Pennsylvania, Philadelphia, PA, USA.
3: Queen's University, Kingston, ON, Canada.
4: Pain Research Informatics, Multimorbidities and Education Center, VA Connecticut Healthcare, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA.
5: Analgesic Solutions, Natick, MA, USA; Tufts University, Boston, MA, USA.
6: United States Food and Drug Administration, Silver Spring, MD, USA.
7: California Pacific Medical Center Research Institute, San Francisco, CA, USA.
8: University of Washington, Seattle, WA, USA.
9: University of Rochester, Rochester, NY, USA.

Associated clinical trials:

A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain. | NCT05025787